Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: Epidemiological benefit from established health resources

Journal of Viral Hepatitis

Volumn 16, Issue 10, 2009, Pages 743-748

  Wiegand, J ^a   Luz, B ^b   Mengelkamp, A K ^c   Moog, R ^d   Koscielny, J ^e   Halm Heinrich, I ^f   Susemihl, C ^g   Bentzien, F ^h   Diekmann, J ⁱ   Wernet, D ^j   Karger, R ^k   Angert, K ^l   Schmitt Thomssen, A ^m   Kiefel, V ⁿ   Lutter, K ^o   Hesse, R ^p   Katzel R ^q   Opitz, A ^r   Luhm, J ^s   Barz, D ^t   Leib, U ^u   Matthes, G ^v   Tillmann, H L ^a,w   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KLINIKUM STUTTGART   (Germany)

^c Institut für Transfusionsmedizin Dortmund   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^g EVANGELISCHES KRANKENHAUS   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^k PHILIPPS UNIVERSITY MARBURG   (Germany)

^l UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^m HANNOVER MEDICAL SCHOOL   (Germany)

ⁿ ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^o Neurologische Klinik Kreiskrankenhaus Freiberg gGmbH   (Germany)

^p KLINIKUM NÜRNBERG   (Germany)

^q Klinikum   (Germany)

^r UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^s UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^t JENA UNIVERSITY HOSPITAL   (Germany)

^u Sudharz Krankenhaus Nordhausen   (Germany)

^v UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^w DUKE CLINICAL RESEARCH INSTITUTE   (United States)

more..

Author keywords

Autologous blood donors; Geographic difference; Hepatitis B virus; Hepatitis C virus; HIV; Syphilis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; GERMAN DEMOCRATIC REPUBLIC; GERMAN FEDERAL REPUBLIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; VIRUS HEPATITIS;

BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; GERMANY, EAST; GERMANY, WEST; HEALTH RESOURCES; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS, VIRAL, HUMAN; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; PREVALENCE;

EID: 70349260633     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01132.x     Document Type: Article

References (15)

1. Wiegand J, Kaiser T, Lobstein S et al. Low prevalence of chronic hepatitis C, but high prevalence of elevated aminotransferases in a cohort of 2026 patients referred for orthopaedic surgery in the eastern part of Germany. Z Gastroenterol 2006 44 (1 11 14.
2. [No authors listed]. Virus hepatitis B, C und D: Situationsbericht Deutschland 2006. Epidemiol Bull 2007 49 : 457 466.
3. Hüppe D, Zehnter E, Mauss S et al. Epidemiology of chronic hepatitis C in Germany - an analysis of 10 326 patients in hepatitis centres and outpatient units. Z Gastroenterol 2008 46 (1 34 44.
4. Offergeld R, Ritter S, Hamouda O. HIV, HCV, HBV and syphilis infections among blood donors in Germany 2005. Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007 50 (10 1221 1231.
5. Slavenburg S, Verduyn-Lunel FM, Hermsen JT, Melchers WJ, te Morsche RH, Drenth JP. Prevalence of hepatitis C in the general population in the Netherlands. Neth J Med 2008 66 (1 13 17.
6. Hamouda O, Marcus U, Voss L, Kollan C. Epidemiology of HIV infections in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 50 (4 399 411.
7. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001 17 (5 429 435.
8. Gemeinsam gegen HIV/AIDS: Netzwerke der HIV/AIDS-Forschung bei EU-Konferenz, http://www.kompetenznetz-hiv.de/presse/716.htm (accessed 12 June 2008).
9. Guadagnino V, Stroffolini T, Rapicetta M et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997 26 (4 1006 1011.
10. Tillmann HL, Manns MP, Rudolph KL. Merging models of hepatitis C virus pathogenesis. Semin Liver Dis 2005 25 (1 84 92.
11. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004 39 (2 476 483.
12. Wiese M, Grüngreiff K, Güthoff W et al. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol 2005 43 (4 590 598.
13. Dore GJ, Freeman AJ, Law M, Kaldor JM. Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 2002 17 (4 423 430.
14. Fu B, Tom BDM, Delahooke T, Alexander GJM, Bird SM. Event-biased referral can distort estimation of hepatitis C virus progression rate to cirrhosis, and of prognostic influences. J Clin Epidemiol 2007 60 (11 1140 1148.
15. Cornberg M, Protzer U, Dollinger MM et al. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. Z Gastroenterol 2007 45 (12 1281 1328.